CCR6 and malignant colon neoplasm: Kapur et al. (2016) reported that C‐C motif chemokine receptor 6 (CCR6) level is higher in colon cancer cases compared with normal adjacent tissue, and CCR6 might be a potential therapeutic target as well as a biomarker in addition to nodal status for predicting therapeutic options.